ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
美国抗疫概念
1,327.58
-9.1315
-0.68%
涨家数:
5
跌家数:
15
平家数:
- -
市盈率:
- -
高:
1,343.21
开:
1,342.69
低:
1,326.57
收:
1,336.71
数据加载中...
总览
新闻资讯
美国 FDA 顾问将于 5 月 22 日讨论 COVID-19 疫苗建议
路透中文
·
05-08
Aethlon Medical, Inc.盘中异动 大幅下挫5.69%报0.361美元
市场透视
·
05-07
背景资料-欧洲企业因经济放缓而裁员
路透中文
·
05-07
安序源科技赴港IPO:连续两年亏损,阿斯利康中金、云锋基金等参投
面包财经
·
05-07
辉瑞5月6日成交额为14.15亿美元
市场透视
·
05-07
阿斯利康5月6日成交额为3.40亿美元
市场透视
·
05-07
雅培5月6日成交额为8.35亿美元
市场透视
·
05-07
美股抗疫概念股表现疲软,Moderna跌超12%
每日经济新闻
·
05-07
BUZZ-FDA 任命 Vinay Prasad 为最高疫苗官员后,基因疗法和疫苗制造商业绩下滑
路透中文
·
05-07
吉利德科学下跌5.02%,报97.645美元/股,总市值1215.68亿美元
金融界
·
05-07
Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报3.39美元
市场透视
·
05-07
辉瑞盘中异动 大幅下跌3.00%报23.16美元
市场透视
·
05-07
诺瓦瓦克斯医药盘中异动 股价大跌5.26%报5.94美元
市场透视
·
05-07
强生4亿美元买的基因疗法,3期失败了
新浪医药
·
05-07
太平洋医药日报:阿斯利康BREZTRI三期临床成功
太平洋证券股份...
·
05-07
阿斯利康(AZN)BTK抑制剂新适应症获欧盟批准
金吾财讯
·
05-06
Ocugen, Inc.盘中异动 股价大跌5.21%
市场透视
·
05-06
吉利德科学跌2.78% 股价跌破100美元大关
市场透视
·
05-06
Biontech Se跌1.38% 股价跌破100美元大关
市场透视
·
05-06
Co-Diagnostics, Inc.盘中异动 股价大涨7.21%报0.378美元
市场透视
·
05-06
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=3®ion=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1327.5806,"timestamp":1746820799999,"preClose":1336.712,"halted":0,"volume":113582454,"delay":0,"changeRate":-0.006831,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-9.13147,"latestTime":"05-09 16:00:00 EDT","open":1342.69,"high":1343.2052,"low":1326.5701,"amount":4653162209.902576,"amplitude":0.012445,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.565313,"peRate":21.186942,"turnoverRate":0.007317,"increases":5,"decrements":15,"flats":0,"marketCap":1093969830401.5,"floatMarketCap":1075897192963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1343.2052,"amplitude":0.012445,"preClose":1336.712,"low":1326.5701,"pbRate":"3.565313","latestPrice":1327.5806,"volume":113582454,"delay":0,"open":1342.69,"prevYearClose":1274.8187,"prevWeekClose":1375.2667,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1375.2667,"twentyDayClose":1281.7616,"sixtyDayClose":1380.7908,"secType":"PLATE","market":"US","turnoverRate":0.007317,"peRate":21.186942,"marketCap":1093969830401.5,"floatMarketCap":1075897192963,"timestamp":1746820799999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533244954","title":"美国 FDA 顾问将于 5 月 22 日讨论 COVID-19 疫苗建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2533244954","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533244954?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 01:43","pubTimestamp":1746639830,"startTime":"0","endTime":"0","summary":"更新 1-美国 FDA 顾问将于 5 月 22 日讨论 COVID-19 疫苗建议在第 2 至 4 段中增加背景介绍。路透5月7日 - 美国食品和药物管理局周三表示,将于 5 月 22 日召开专家会议,讨论 COVID-19 疫苗对即将开展的免疫接种活动的建议。此次会议是在美国食品和药物管理局局长马丁-马卡里被任命后召开的,马卡里曾对COVID-19大流行期间的一些公共卫生工作表示担忧,并反对强制要求公众接种疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL4S3RF220:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU1883839398.USD","LU0306807586.USD","SG9999013999.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU0122379950.USD","BK4550","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4551","BK4547","LU0985481810.HKD","BK4585","LU1066051498.USD","MRNA","SG9999011175.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU0170899867.USD","BK4599","SG9999002232.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","SG9999003800.SGD","BK4501","IE0002270589.USD","BK4588","BK4533","LU1894683348.USD","IE00BBT3K403.USD","NVAX","PFE","IE00BLSP4239.USD","LU0306806265.USD","BK4534","LU0868494617.USD","LU0456855351.SGD","BK4568","LU0234572021.USD","LU1894683264.USD","BK4581","BK4592","BK4007","SG9999002224.SGD","LU1066053197.SGD","LU0321505439.SGD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2533958551","title":"Aethlon Medical, Inc.盘中异动 大幅下挫5.69%报0.361美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533958551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533958551?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 23:02","pubTimestamp":1746630140,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日23时02分,Aethlon Medical, Inc.股票出现波动,股价大幅下跌5.69%。截至发稿,该股报0.361美元/股,成交量2.2672万股,换手率0.14%,振幅2.64%。Aethlon Medical, Inc.股票所在的医疗器械行业中,整体跌幅为0.07%。其相关个股中,Nortech Systems Incorporated、Livanova Plc、Dih Holdings Us Inc C/Wts 20/04/2028 涨幅较大,Invo Fertility, Inc.、Reshape Lifesciences, Inc.、Nortech Systems Incorporated较为活跃,换手率分别为33.70%、29.95%、9.41%,振幅较大的相关个股有Tenon Medical Inc C/Wts 16/06/2028 、Nortech Systems Incorporated、Standard Biotools Inc.,振幅分别为33.33%、28.30%、22.64%。Aethlon Medical, Inc.公司简介:Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507230220975216f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507230220975216f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4568","BK4583","AEMD"],"gpt_icon":0},{"id":"2533603194","title":"背景资料-欧洲企业因经济放缓而裁员","url":"https://stock-news.laohu8.com/highlight/detail?id=2533603194","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533603194?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 17:47","pubTimestamp":1746611233,"startTime":"0","endTime":"0","summary":"路透5月7日 - 严峻的经济形势和对许多产品持续疲软的需求迫使欧洲各地的公司冻结招聘或裁员。* 雷诺rena.pa:这家法国汽车制造商于 3 月 11 日表示, ,将在桑杜维尔的面包车工厂裁员 300 人,以应对欧洲商用车需求的放缓。* 蒂森克虏伯 tkag.de:这家德国企业集团于 3 月 6 日表示,由于其供应的汽车行业长期疲软,计划裁员约 1800 人, 。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL4S3RF0X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","BK4551","BK4535","BK4585","BK4588","BK4568","BNTX"],"gpt_icon":0},{"id":"2533962879","title":"安序源科技赴港IPO:连续两年亏损,阿斯利康中金、云锋基金等参投","url":"https://stock-news.laohu8.com/highlight/detail?id=2533962879","media":"面包财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533962879?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 13:38","pubTimestamp":1746596280,"startTime":"0","endTime":"0","summary":"4月30日,安序源科技Axbio International Limited(以下简称 “安序源科技\")在港交所递交招股书,拟香港主板挂牌上市,中金公司和浦银国际担任联席保荐人。安序源科技是一家集成电路生物科技企业。据招股书显示,安序源科技最近两年来连续亏损,且尚未从在研产品的商业销售中产生收入。集成电路生物科技企业 连续两年亏损安序源科技成立于2016年,主要产品包括分子诊断产品、用于多组学分析","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050713390594eeda1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050713390594eeda1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1829250122.USD","LU2462157665.USD","BK4568","LU2417539215.USD","LU2456880835.USD","LU0889565916.HKD","LU0320765992.SGD","BK4585","LU0109394709.USD","BK4588","BK4007","AZN","LU2236285917.USD"],"gpt_icon":0},{"id":"2533617506","title":"辉瑞5月6日成交额为14.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533617506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533617506?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 10:24","pubTimestamp":1746584661,"startTime":"0","endTime":"0","summary":"美东时间2025年5月6日,辉瑞成交额为14.15亿美元,成交额较昨日增加44.73%,当日成交量为6087.26万股。辉瑞于2025年5月6日跌4.15%,报22.88美元,该股过去5个交易日跌3.83%,年初至今跌12.33%,过去60日跌11.11%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-06|14.15亿|44.73%|6087.26万|#|2025-05-05|9.78亿|-2.97%|4081.18万|#|2025-05-02|10.08亿|-10.53%|4168.58万|#|2025-05-01|11.26亿|-13.93%|4689.17万|#|2025-04-30|13.08亿|-43.87%|5394.17万|辉瑞是全球最大的制药公司之一,年销售额接近500亿美元。辉瑞在全球销售这些产品,国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507102429a474bad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507102429a474bad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051498.USD","LU1057294990.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU0234572021.USD","LU0306806265.USD","SG9999003800.SGD","BK4581","LU0225771236.USD","LU1894683348.USD","IE00B19Z3581.USD","SG9999002224.SGD","LU0058720904.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0122379950.USD","LU0321505439.SGD","SG9999001176.USD","LU1883839398.USD","BK4568","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4550","LU0289739699.SGD","LU0868494617.USD","LU0456855351.SGD","LU0306807586.USD","LU0985481810.HKD","SG9999002232.USD","BK4585","IE00BLSP4239.USD","SG9999013999.USD","BK4592","PFE","SG9999011175.SGD","SGXZ57979304.SGD","BK4534","LU1066053197.SGD","LU1894683264.USD","BK4007","BK4599","IE00BLSP4452.SGD","BK4533","LU0225284248.USD","BK4588","LU1023059063.AUD"],"gpt_icon":1},{"id":"2533195256","title":"阿斯利康5月6日成交额为3.40亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533195256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533195256?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 09:17","pubTimestamp":1746580625,"startTime":"0","endTime":"0","summary":"美东时间2025年5月6日,阿斯利康成交额为3.40亿美元,成交额较昨日增加54.27%,当日成交量为480.22万股。阿斯利康于2025年5月6日跌2.54%,报70.26美元,该股过去5个交易日跌2.02%,年初至今涨8.98%,过去60日跌0.96%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-06|3.40亿|54.27%|480.22万|#|2025-05-05|2.20亿|-43.09%|305.57万|#|2025-05-02|3.87亿|-5.31%|537.45万|#|2025-05-01|4.09亿|40.45%|582.01万|#|2025-04-30|2.91亿|-48.32%|405.73万|1999 年,瑞典阿斯特拉公司与英国捷利康集团合并,成立了阿斯利康公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507091726a6d5a943&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507091726a6d5a943&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AZN","LU0320765992.SGD","LU1829250122.USD","LU2417539215.USD","BK4568","BK4585","LU2456880835.USD","BK4588","LU2236285917.USD","LU2462157665.USD","LU0109394709.USD","BK4007","LU0889565916.HKD"],"gpt_icon":0},{"id":"2533619599","title":"雅培5月6日成交额为8.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533619599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533619599?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 09:15","pubTimestamp":1746580516,"startTime":"0","endTime":"0","summary":"美东时间2025年5月6日,雅培成交额为8.35亿美元,成交额较昨日增加9.52%,当日成交量为629.05万股。雅培于2025年5月6日涨0.35%,报133.06美元,该股过去5个交易日涨1.96%,年初至今涨18.8%,过去60日涨3.57%。雅培约 60% 的销售额来自美国以外地区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507091535a6d5a899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507091535a6d5a899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","BK4082","BK4568","BK4581","LU1691799644.USD","IE00BJJMRZ35.SGD","LU1989763427.SGD","LU0122379950.USD","LU2133065610.SGD","SG9999004303.SGD","LU2089984988.USD","LU2468319806.SGD","LU2112291526.USD","LU1721429741.USD","LU1721429402.USD","IE00B2B36J28.USD","BK4588","LU0234572021.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","ABT","LU0266013472.USD","LU1023059063.AUD","BK4504","BK4585","SGXZ23171101.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","IE0002141913.USD","IE0009355771.USD","LU2237957811.SGD","SG9999002224.SGD","LU1989763690.USD","LU0868494617.USD","BK4566","LU1057294990.SGD","BK4533","LU1914381329.SGD","IE00B4R5TH58.HKD","LU2237957902.USD","BK4592"],"gpt_icon":0},{"id":"2533258696","title":"美股抗疫概念股表现疲软,Moderna跌超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533258696","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533258696?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 06:14","pubTimestamp":1746569668,"startTime":"0","endTime":"0","summary":"每经AI快讯,5月7日,美股抗疫概念股表现疲软,Moderna跌超12%,吉利德科学跌逾4%,诺瓦瓦克斯医药跌超3%,BioNTech跌逾6%,阿斯利康跌超2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505073397198798.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505073397198798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B3T34201.USD","LU1066051498.USD","LU1778281490.HKD","LU0289739699.SGD","LU1430594728.SGD","LU1674673691.USD","LU1585245621.USD","NVAX","LU0109394709.USD","BK4568","IE00BSNM7G36.USD","IE0002270589.USD","BK4532","IE00BKVL7J92.USD","BK4583","LU2468319806.SGD","IE00B19Z3B42.SGD","BK4578","LU1674673428.USD","LU1839511570.USD","LU2087621335.USD","LU0320765992.SGD","BK4588","BK4566","GILD","LU2089984988.USD","IE00B19Z3581.USD","LU0058720904.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","BK4585","BK4139","BK4547","IE00BZ1G4Q59.USD","LU1571399168.USD","LU0889565916.HKD","BK4550","LU0234570918.USD"],"gpt_icon":0},{"id":"2533663164","title":"BUZZ-FDA 任命 Vinay Prasad 为最高疫苗官员后,基因疗法和疫苗制造商业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2533663164","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533663164?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 02:20","pubTimestamp":1746555659,"startTime":"0","endTime":"0","summary":"5月6日 - ** 在美国 FDA 任命 Vinay Prasad 担任其生物制品评估与研究中心主任 ** 普拉萨德是 COVID-19 疫苗和面罩任务的激烈批评者 ** 作为 CBER 主任,普拉萨德将负责疫苗和基因疗法的监管工作** 莫德纳股价下跌12.4%,NovavaxNVAX.O下跌5.2%,而辉瑞PFE.N此前在宣布 药品成本后下跌,其跌幅扩大至3%。** Sarepta Therapeutics SRPT.O等基因治疗开发商股价下跌21.5%,Taysha Gene Therapies TSHA.O下跌20.7%,Capricor Therapeutics CAPR.O下跌20.3%。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4T3RE1W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","IE00B2B36J28.USD","SG9999011175.SGD","BK4547","LU0456855351.SGD","LU0306806265.USD","BK4534","IE00BJT1NW94.SGD","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4139","CAPR","IE0009355771.USD","BK4548","BK4581","IE0002270589.USD","LU0985481810.HKD","BK4551","SG9999001176.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","IE0002141913.USD","LU1066051498.USD","LU0058720904.USD","MRNA","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","TSHA","BK4532","IE00BLSP4452.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","SRPT","SG9999002224.SGD","SG9999002232.USD","NVAX","SLDB","BK4501","BK4568","LU0868494617.USD","BK4533","LU1883839398.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2533206668","title":"吉利德科学下跌5.02%,报97.645美元/股,总市值1215.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533206668","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533206668?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 01:55","pubTimestamp":1746554148,"startTime":"0","endTime":"0","summary":"5月7日,吉利德科学(GILD)盘中下跌5.02%,截至01:55,报97.645美元/股,成交5.47亿美元,总市值1215.68亿美元。财务数据显示,截至2025年03月31日,吉利德科学收入总额66.67亿美元,同比减少0.28%;归母净利润13.15亿美元,同比增长131.53%。资料显示,吉利德科学公司是一家研究型生物制药公司,其使命在于发现并满足医疗领域的需求,开发和商业化创新药物。 该公司努力简化对于世界各地各种疾病的治疗。 吉利德的产品组合和研发药物包括治疗艾滋病毒/艾滋病,肝脏疾病,癌症,炎症和呼吸系统疾病以及心血管疾病。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/07015550176990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4588","IE00B19Z3B42.SGD","LU1839511570.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4585","LU0234570918.USD","GILD","LU1778281490.HKD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4583","BK4550","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4139","IE00B19Z3581.USD","LU1066051498.USD","BK4532","LU0109394709.USD","LU1571399168.USD","LU2087621335.USD","BK4566","LU1585245621.USD","LU1674673428.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU1430594728.SGD","LU2468319806.SGD","BK4568","IE0002270589.USD","LU1674673691.USD","BK4578","LU0320765992.SGD"],"gpt_icon":0},{"id":"2533650017","title":"Corvus Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533650017?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 01:41","pubTimestamp":1746553265,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时41分,Corvus Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.05%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为5.88%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 、Sol-Gel Technologies Ltd.涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为8113.01%、1208.33%、527.98%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 、Protagenic Therapeutics, Inc.,振幅分别为162.68%、69.05%、47.02%。Corvus Pharmaceuticals, Inc.公司简介:Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070141059750ecfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070141059750ecfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4568","BK4139"],"gpt_icon":0},{"id":"2533865006","title":"辉瑞盘中异动 大幅下跌3.00%报23.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533865006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533865006?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 01:24","pubTimestamp":1746552247,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时24分,辉瑞股票出现异动,股价大幅跳水3.00%。截至发稿,该股报23.16美元/股,成交量2815.38万股,换手率0.50%,振幅3.06%。最近的财报数据显示,该股实现营业收入137.15亿美元,净利润29.67亿美元,每股收益0.52美元,毛利98.27亿美元,市盈率16.78倍。辉瑞股票所在的制药行业中,整体跌幅为2.91%。辉瑞公司简介:辉瑞是全球最大的制药公司之一,年销售额接近500亿美元。辉瑞在全球销售这些产品,国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012407a4744798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012407a4744798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2533579216","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.26%报5.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533579216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533579216?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 00:44","pubTimestamp":1746549851,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时44分,诺瓦瓦克斯医药股票出现异动,股价快速跳水5.26%。截至发稿,该股报5.94美元/股,成交量284.182万股,换手率1.75%,振幅5.42%。机构评级方面,在所有7家参与评级的机构中,57%的券商给予买入建议,29%的券商给予持有建议,14%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为5.33%。公司认为其疫苗技术有潜力广泛应用于多种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004411a4744122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004411a4744122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4547","BK4588","NVAX","BK4568","BK4139"],"gpt_icon":0},{"id":"2533579446","title":"强生4亿美元买的基因疗法,3期失败了","url":"https://stock-news.laohu8.com/highlight/detail?id=2533579446","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533579446?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 00:02","pubTimestamp":1746547340,"startTime":"0","endTime":"0","summary":"2023年12月底,强生公司以一项价值高达4.15亿美元的交易买下了该计划的全部权利。然而近日公布的三期数据,给基因疗法又破了一盆冷水。2025年2月,辉瑞宣布停止其B型血友病基因疗法Beqvez的开发和商业化,主要原因是获批近1年,未有患者接受商业化治疗。至此,辉瑞的产品管线中不再包含任何处于临床或商业化阶段的基因疗法。被寄予厚望的基因疗法,近期接连受挫。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507003007a4743d6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507003007a4743d6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","BK4504","LU1506573853.SGD","LU1057294990.SGD","LU1221951129.SGD","LU2129689605.HKD","LU2505996681.GBP","LU2089984988.USD","IE00B2B36J28.USD","BK4585","LU0203347892.USD","IE00B42XCP33.USD","IE00BJT1NW94.SGD","LU0640476718.USD","LU0792757196.USD","IE00BVYPNV92.GBP","IE00B3T34201.USD","LU0058720904.USD","LU2602419157.SGD","IE00BLSP4452.SGD","JNJ","LU1061106388.HKD","LU0882574055.USD","LU1267930813.SGD","LU1732800096.USD","LU2430703095.HKD","IE0002270589.USD","LU1935042991.SGD","BK4588","LU2112291526.USD","LU0795875086.SGD","LU2505996509.AUD","LU0345770308.USD","IE00B1BXHZ80.USD","LU1585245621.USD","IE00BLSP4239.USD","LU1196500208.SGD","BK4534","IE00BDGV0183.EUR","LU1066051225.USD","BK4568","IE0034235303.USD","LU1894683264.USD","LU1914381329.SGD","LU1162221912.USD","IE00B3PB1722.GBP","SG9999002224.SGD","LU0289739699.SGD","LU1066053197.SGD","LU1732799900.SGD"],"gpt_icon":0},{"id":"2533667622","title":"太平洋医药日报:阿斯利康BREZTRI三期临床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2533667622","media":"太平洋证券股份...","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533667622?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 00:00","pubTimestamp":1746547200,"startTime":"0","endTime":"0","summary":"行业要闻:近日,阿斯利康宣布,三联吸入气雾剂Breztri在哮喘控制不佳患者中进行的两项3期临床试验KALOS 和LOGOS 中获得积极顶线结果。Breztri 是一种吸入式三联组合疗法,目前已在包括美国、欧盟、中国和日本在内的全球80 多个国家和地区获批用于治疗成人慢性阻塞性肺病。众生药业:公司发布公告,子公司众生睿创自主研发的RAY1225 注射液于近日获得减重和降糖两项II 期临床试验剂量扩展组的顶线分析数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505071504509751a0e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505071504509751a0e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AZN","BK4585","LU2462157665.USD","LU1829250122.USD","BK4007","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","LU0109394709.USD","LU2456880835.USD","BK4568"],"gpt_icon":0},{"id":"2533590416","title":"阿斯利康(AZN)BTK抑制剂新适应症获欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2533590416","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533590416?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 23:20","pubTimestamp":1746544807,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿斯利康(AZN)宣布,阿可替尼与苯达莫司汀和利妥昔单抗联合使用已在欧盟获得批准,用于治疗未接受过治疗且不适合接受自体干细胞移植的套细胞淋巴瘤(MCL)成年患者。新闻稿指出,这是欧盟首个也是唯一一个获批用于该适应症的BTK抑制剂。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"288224","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU1829250122.USD","LU2462157665.USD","BK4588","LU2236285917.USD","LU0889565916.HKD","LU0320765992.SGD","LU2417539215.USD","AZN","BK4007","LU2456880835.USD","LU0109394709.USD","BK4585"],"gpt_icon":0},{"id":"2533653353","title":"Ocugen, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533653353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533653353?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 22:26","pubTimestamp":1746541604,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日22时26分,Ocugen, Inc.股票出现波动,股价快速跳水5.21%。截至发稿,该股报0.720美元/股,成交量73.5377万股,换手率0.25%,振幅5.21%。Ocugen, Inc.股票所在的生物技术行业中,整体跌幅为4.23%。Ocugen, Inc.公司简介:Ocugen Inc 公司专注于发现、开发和商业化新型基因和细胞疗法和疫苗,以改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062226449750cb49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062226449750cb49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","OCGN","BK4563"],"gpt_icon":1},{"id":"2533965591","title":"吉利德科学跌2.78% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2533965591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533965591?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 21:57","pubTimestamp":1746539860,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时57分,吉利德科学股票出现波动,股价快速下挫2.78%。截至发稿,该股报99.95美元/股,成交量54.5592万股,换手率0.04%,振幅2.62%。吉利德科学股票所在的制药行业中,整体跌幅为1.61%。吉利德科学公司简介:吉利德科学开发和营销用于治疗威胁生命的传染病的疗法,其投资组合的核心集中在艾滋病毒,乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050621574094ee12fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050621574094ee12fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B3T34201.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1571399168.USD","LU1674673691.USD","BK4139","IE0002270589.USD","LU0320765992.SGD","LU1585245621.USD","BK4568","LU0234570918.USD","LU0058720904.USD","LU2468319806.SGD","BK4550","LU0109394709.USD","BK4583","LU1839511570.USD","LU2087621335.USD","LU2089984988.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","BK4585","LU1066053197.SGD","LU0889565916.HKD","BK4566","IE00BSNM7G36.USD","BK4578","IE00B19Z3581.USD","IE00BKVL7J92.USD","BK4588","BK4532","LU1430594728.SGD","LU1066051498.USD","GILD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2533655506","title":"Biontech Se跌1.38% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2533655506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533655506?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 21:32","pubTimestamp":1746538364,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时32分,Biontech Se股票出现异动,股价大幅跳水1.38%。Biontech Se股票所在的生物技术行业中,整体跌幅为2.63%。消息层面,截至21时32分,《BioNTech SE第一季度营收1.828亿欧元》资讯为影响Biontech Se的重要信息。该信息摘要如下:格隆汇5月5日|BioNTech SE第一季度营收为1.828亿欧元,每股亏损1.73欧元;仍预计本财年研发支出为26亿至28亿欧元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506213244a6d5194a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506213244a6d5194a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BNTX","BK4535","BK4139","KTTA","BK4585","BK4568","BK4588","BK4548"],"gpt_icon":0},{"id":"2533634990","title":"Co-Diagnostics, Inc.盘中异动 股价大涨7.21%报0.378美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533634990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533634990?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 21:32","pubTimestamp":1746538349,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时32分,Co-Diagnostics, Inc.股票出现波动,股价大幅拉升7.21%。截至发稿,该股报0.378美元/股,成交量2107股,换手率0.01%,振幅0.00%。Co-Diagnostics, Inc.股票所在的医疗器械行业中,整体跌幅为0.53%。其相关个股中,UFP技术、Envoy Medical, Inc.、Artivion, Inc.涨幅较大,Invo Fertility, Inc.、Nanovibronix, Inc.、Reshape Lifesciences, Inc.较为活跃,换手率分别为36.88%、2.89%、2.81%,振幅较大的相关个股有Orthofix Medical Inc.、Si-Bone, Inc.、Neuronetics, Inc.,振幅分别为10.49%、10.12%、9.56%。Co-Diagnostics, Inc.公司简介:Co-Diagnostics Inc是一家分子诊断公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506213229a47416ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506213229a47416ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CODX","BK4082","BK4568"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":187,"code":"91000000","status":"200"}]}}